Houston, Texas 77030


Purpose:

Objectives: To determine if the use of botulinum toxin during primary cleft lip repair improves the cosmetic appearance of the scar Study Design: Double blinded randomized controlled trial Methods: Study to be completed at an academic tertiary hospital. Patients must be 6 months of age or younger with a unrepaired complete unilateral cleft lip and palate requiring a primary cheiloplasty. Botulinum toxin will be injected intraoperatively at 4 standardized sites in the cleft lip during surgical repair. Control subjects will receive a placebo injection in place of the toxin. Surgeons will be blinded to patients that receive the experimental injection. Outcomes will be determined using 3D-videography preoperatively and post operatively at scheduled visits with a total of one year follow up. A scar assessment questionnaire will be completed by parents at select post operative visits. Videography images will also be assessed by a blinded expert panel at the completion of the study.


Criteria:

Inclusion Criteria: Unilateral cleft lip with or without cleft palate, less than 6 months of age Exclusion Criteria: Bilateral cleft lip, older than 6 months of age


NCT ID:

NCT02247193


Primary Contact:

Principal Investigator
Jaecel O Shah, MD
UTHealth

Jaecel O Shah, MD
Email: jaecel.o.shah@uth.tmc.edu


Backup Contact:

Email: John.F.Teichgraeber@uth.tmc.edu
John F Teichgraeber, MD
Phone: 713.500.7285


Location Contact:

Houston, Texas 77030
United States

Carol Underwood, BSN/RN
Phone: 713-704-4230

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 17, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.